FCMV
Foresite Capital Management V Portfolio holdings
AUM
$80.7M
This Quarter Return
-16.17%
1 Year Return
-24.46%
3 Year Return
+66.81%
5 Year Return
–
10 Year Return
–
AUM
$87.6M
AUM Growth
+$87.6M
(-27%)
Cap. Flow
-$19.8M
Cap. Flow
% of AUM
-22.64%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
1
Reduced
1
Closed
1
Top Buys
| 1 |
CG Oncology
CGON
|
$4.08M |
| 2 |
MAZE
Maze Therapeutics, Inc. Common Stock
MAZE
|
$3.8M |
Top Sells
| 1 |
Hims & Hers Health
HIMS
|
$19.7M |
| 2 |
Cullinan Oncology
CGEM
|
$8.01M |
Sector Composition
| 1 | Healthcare | 90.79% |
| 2 | Consumer Staples | 9.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALMS
1
Alumis Inc. Common Stock
ALMS
$479M
| $35.5M | 40.5% | 5,779,348 | – | – |
|
|
2
CG Oncology
CGON
$2.04B
| $21M | 24.01% | 859,050 +166,500 | +24% | +$4.08M |
|
3
Disc Medicine
IRON
$2.07B
| $14.8M | 16.94% | 299,069 | – | – |
|
|
4
Hims & Hers Health
HIMS
$9.57B
| $8.07M | 9.21% | 273,151 -666,709 | -71% | -$19.7M |
|
5
Lyell Immunopharma
LYEL
$213M
| $4.38M | 4.99% | 8,133,047 | – | – |
|
|
MAZE
6
Maze Therapeutics, Inc. Common Stock
MAZE
$635M
| $3.8M | 4.34% | +345,191 | New | +$3.8M |
|
|
7
Cullinan Oncology
CGEM
$445M
| – | – | -657,905 | Closed | -$8.01M |
|